The company designs and manufactures woven apparel for international and domestic fashion brands, operating integrated production and washing facilities to supply ready-made garments.
The company lacks a durable moat, as evidenced by its inability to maintain profitability following the exit of a major customer (VF Corporation). While it claims expertise in woven apparel, the lack of pricing power is confirmed by the need to absorb significant tariff costs and the persistent negative net margins and ROE.
Capital allocation has been poor, characterized by reinvestment into manufacturing capacity that was subsequently shuttered (Avadi facility) and the issuance of equity to redeem preference shares while the business was incurring heavy losses.
The company's collapse was a slow-motion train wreck driven by a toxic combination of excessive leverage and a lack of competitive relevance. After losing a cornerstone client, the business failed to replace the volume at profitable rates, instead absorbing rising costs and tariffs that further eroded its already negative margins. The massive debt load eventually became a noose as interest coverage remained negative, leading to a liquidity crisis where the 'material uncertainty' flagged by auditors finally manifested in a total cessation of operations or a fire-sale liquidation that wiped out common shareholders.
RichFakir rates Celebrity Fashions Ltd's business quality as poor — 11/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Celebrity Fashions Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Celebrity Fashions Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Celebrity Fashions Ltd's fair value is about ₹2 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →